Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 8,301 | 5,773 | 5,318 | 1,461 | 1,254 |
| Cost of Goods | 2,141 | 1,800 | 1,625 | 3,927 | 5,177 |
| Gross Profit | 6,160 | 3,973 | 3,693 | -2,466 | -3,923 |
| Operating Expenses | 45,272 | 42,627 | 42,279 | 37,358 | 34,401 |
| Operating Income | -38,971 | -37,854 | -37,961 | -38,897 | -38,147 |
| Interest Expense | 4,598 | 2,734 | 2,751 | 2,735 | 2,691 |
| Other Income | 856 | 916 | 743 | 1,104 | 1,394 |
| Pre-tax Income | -42,713 | -39,672 | -39,969 | -40,528 | -39,444 |
| Net Income Continuous | -42,713 | -39,672 | -39,969 | -40,528 | -39,444 |
| Net Income | $-42,713 | $-39,672 | $-39,969 | $-40,528 | $-39,444 |
| EPS Basic Total Ops | -0.66 | -0.62 | -0.64 | -0.65 | -0.63 |
| EPS Basic Continuous Ops | -0.66 | -0.62 | -0.64 | -0.65 | -0.63 |
| EPS Diluted Total Ops | -0.66 | -0.62 | -0.64 | -0.65 | -0.63 |
| EPS Diluted Continuous Ops | -0.66 | -0.62 | -0.64 | -0.65 | -0.63 |
| EBITDA(a) | $-34,988 | $-32,900 | $-34,940 | $-34,686 | $-35,519 |